Sanofi-Aventis kept by Bear at outperform

Sanofi-Aventis was retained by Bear Stearns analyst Alexandra Hauber at an outperform rating with a price target on the stock of €77 per share on analysis from its second-quarter earnings of potential for its weight loss drug Acomplia, which is also being studied as a treatment for diabetes and cardiovascular conditions. On the Paris exchange, Sanofi-Aventis shares Thursday were down €1.05, or 1.55%, at €66.60 on volume of 5,512,360 shares versus the three-month running average of 3,590,090 shares. In the United States, Sanofi-Aventis shares Thursday were off $0.58, or 1.38%, at $41.37 on volume of 1,480,100 shares versus the three-month running average of 1,182,540 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.